OverviewChartNews

Japanese Yen Futures (6J June 2024)/  XFTT6JCMEGLB  /  CME GLOBEX

5/30/2024 12:21:33 PM Chg. +0.000021 Bid12:21:47 PM Ask12:21:47 PM Open High Low Previous Close
0.006382USD +0.33% 0.006382 0.006383 0.006359 0.006405 0.006358 0.006362
GlobeNewswire 5/13 Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors...
GlobeNewswire 5/2 Using clinical-led AI, Truveta expands clinical notes and medical images available to advance resear...
GlobeNewswire 11/3/2023 Elicio Therapeutics Presents Updated Preliminary Immunogenicity Data from the Ongoing Phase 1 Study ...
GlobeNewswire 8/24/2023 pMD®️ Unveils New Branding To Improve Transparency And Value For Customers
GlobeNewswire 8/21/2023 Taiwan Excellence Shines Spotlight on Sustainability at Pop-Up Experience in Seattle
GlobeNewswire 7/14/2021 Revamped King of Hemp Website Goes Live, Online Store Ready for Orders
GlobeNewswire 10/15/2020 Checkmate Pharmaceuticals Announces Data Presentations for CMP-001 at The Society for Immunotherapy ...
GlobeNewswire 10/12/2020 Nokia: 5G set to add $8trn to global GDP by 2030
TeleTrader 7/30/2020 China confirms carrying out drills in South China Sea
GlobeNewswire 4/7/2020 Pixelworks Announces Preliminary First Quarter 2020 Financial Results
GlobeNewswire 1/22/2020 Greystone’s Latest Insights Magazine is Released
GlobeNewswire 10/29/2019 Worldwide Mobile Money Modernisation & Monetisation in Payments, Retail, Commerce & Banking 2019 to ...
GlobeNewswire 10/8/2019 AVX Releases New Automotive-Qualified Multilayer Varistors with Competitively Low Clamping-to-Workin...
GlobeNewswire 9/12/2019 Salarius Pharmaceuticals Supports Childhood Cancer Awareness Month
GlobeNewswire 4/29/2019 Voyager Therapeutics Announces New Data in Multiple Presentations at the American Society of Gene an...
GlobeNewswire 4/10/2019 Sorrento Therapeutics Announces Discovery of a Potential Non-Dopaminergic Approach to Controlling Pa...
GlobeNewswire 7/9/2018 Light Reading Launches New Live Event: Cable Next-Gen Europe in London
GlobeNewswire 10/15/2010 NEW DATA EVALUATING LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS DEMONSTRATE NEUROPROTECTIVE E...